Advanced Relapsed Or Refractory Ovarian Cancer clinical trials

Explore recruiting advanced relapsed or refractory ovarian cancer clinical trials.

Recruiting advanced relapsed or refractory ovarian cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Relapsed Or Refractory Ovarian Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to test how well different doses of BI 3820768 are tolerated by people with advanced cancer (solid tumours)

Spain, France, Belgium, Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Advanced Relapsed Or Refractory Ovarian Cancer trials by city

Advanced Relapsed Or Refractory Ovarian Cancer clinical trials

Recruiting advanced relapsed or refractory ovarian cancer studies right now

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

A Study of PHST001 in Advanced Solid Tumors

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

Also recruiting in Europe

A study to test how well different doses of BI 3820768 are tolerated by people with advanced cancer (solid tumours)

Advanced Relapsed Or Refractory Ovarian Cancer trials by city

Other conditions